Nontuberculous Mycobacterial Lung DiseaseSymptoms, Doctors, Treatments, Advances & More
Nontuberculous Mycobacterial Lung Disease Overview
Learn About Nontuberculous Mycobacterial Lung Disease
OHSU Hospital
Kevin Winthrop is a primary care provider, practicing in Internal Medicine in Portland, Oregon. Dr. Winthrop is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Mycobacterium Avium Complex Infections, Shingles, Bronchiectasis, Cataract Removal, and Lung Transplant. Dr. Winthrop is currently accepting new patients.
University Medical Associates Of The Medical University Of South Carol
Patrick Flume is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Charleston, South Carolina. Dr. Flume is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Lung Transplant. Dr. Flume is currently accepting new patients.
Ronald Severino is a primary care provider, practicing in Family Medicine in Wheaton, Illinois. Dr. Severino is rated as a Distinguished provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease, Hyperlipidemia Type 3, Mycobacterium Avium Complex Infections, and Premature Ovarian Failure. Dr. Severino is board certified in American Board Of Family Medicine - Family Medicine (Certified). Dr. Severino is currently accepting new patients.
Summary: This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment for patients with nontuberculous mycobacterial infections. Blood and airway samples will be obtained from follow up visits of patients with refractory bacterial infections that are considered for phage therapy. Samples will be compared betw...
Summary: This multicenter randomized controlled trial evaluates the clinical and microbiological effects of inhaled 3% hypertonic saline in treatment-naïve patients with nontuberculous mycobacterial lung disease (NTM-LD). Participants are randomized in a 1:1 ratio to either early initiation of 3% hypertonic saline for 6 months or delayed initiation consisting of normal saline inhalation during the first 3 ...
